NYSE$CRL
Charles River Laboratories International Inc · Q4 2020 earnings
Q4 2020 earnings · · Investor relations
Briefing
Announced fourth-quarter and full-year 2020 results, exceeding expectations.
Charles River Laboratories reported a strong fourth quarter with revenue of $791.0 million, a 14.4% increase year-over-year. GAAP earnings per share were $2.81, and non-GAAP earnings per share were $2.39. The company also provided 2021 guidance and announced a definitive agreement to acquire Cognate BioServices.
- Fourth-quarter revenue reached $791.0 million, up 14.4% from Q4 2019.
- GAAP earnings per share for the fourth quarter were $2.81, while non-GAAP EPS was $2.39.
- Organic revenue growth was 10.3%, driven by all three business segments.
- Charles River announced an agreement to acquire Cognate BioServices, expanding its cell and gene therapy CDMO capabilities.
Headline financials
Revenue & EPS history
Charles River Labs · Revenue · Quarterly
$791M
Revenue by segment
Charles River Labs · $791M total across 3 segments · Q4 2020
- Discovery & Safety Assessment$495M+12.7%62.6%
- Research Models & Services$157M+19.3%19.8%
- Manufacturing Solutions$139M+15.5%17.6%
Forward guidance
Charles River Labs provided revenue, EPS and free cash flow guidance for 2021, excluding the financial impact of the planned acquisition of Cognate. The 2021 revenue growth outlook reflects a continuation of robust client demand trends, as well as a favorable comparison to last year’s revenue impact from the COVID-19 pandemic. Earnings per share in 2021 are expected to benefit from higher revenue and modest operating margin improvement, partially offset by a higher tax rate.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 20 quarterly earnings reports · overlaid with Q4 2020
+0.1%
Avg return
Earnings day
+0.5%
Avg return
5 days after
+0.7%
Avg return
30 days after
47%
32 / 68 earnings
Positive
+18.4%
Q1 2025
Best reaction
-13.3%
Q3 2017
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | +1.8% | -9.0% | -0.1% | |
| Q4 2025 | -1.8% | +3.1% | -3.1% | |
| Q3 2025 | -5.5% | -5.0% | +3.6% | |
| Q1 2025 | +18.4% | +24.0% | +25.4% | |
| Q4 2024 | +6.9% | +10.4% | +8.3% | |
| Q3 2024 | +11.5% | +17.0% | +1.7% | |
| Q2 2024 | -11.7% | -15.1% | -17.8% | |
| Q1 2024 | -3.0% | -1.0% | -8.7% | |
| Q4 2023 | +11.4% | +11.2% | +17.6% | |
| Q3 2023 | -7.3% | -7.0% | +11.8% | |
| Q2 2023 | +5.5% | +5.2% | -3.2% | |
| Q1 2023 | +2.7% | +1.0% | +6.1% | |
| Q4 2022 | -6.7% | -9.0% | -20.4% | |
| Q3 2022 | +4.8% | +9.0% | +7.4% | |
| Q2 2022 | -6.6% | -9.4% | -17.8% | |
| Q1 2022 | -1.2% | -8.9% | -3.3% | |
| Q4 2021 | -6.7% | -6.1% | -8.3% | |
| Q3 2021 | -12.2% | -13.4% | -17.3% | |
| Q2 2021 | -0.3% | -0.4% | +9.3% | |
| Q1 2021 | +4.0% | +3.2% | -0.1% | |
| Q4 2020 | +2.0% | -1.1% | -0.0% | |
| Q3 2020 | +2.6% | +7.0% | +3.7% | |
| Q2 2020 | +6.8% | +7.3% | +0.4% | |
| Q1 2020 | +11.1% | +12.0% | +24.2% | |
| Q4 2019 | +8.6% | +11.9% | -21.3% | |
| Q3 2019 | -2.5% | +1.1% | +12.0% | |
| Q2 2019 | -5.1% | -10.3% | -7.0% | |
| Q1 2019 | -4.2% | -4.1% | -10.4% | |
| Q4 2018 | +8.1% | +9.0% | +11.1% | |
| Q3 2018 | +8.8% | +6.8% | +3.0% | |
| Q2 2018 | -5.2% | -6.6% | -1.6% | |
| Q1 2018 | +0.3% | -1.0% | +8.5% | |
| Q4 2017 | +8.2% | +6.0% | +9.9% | |
| Q3 2017 | -13.3% | -14.3% | -11.9% | |
| Q2 2017 | -1.7% | -0.2% | +10.0% | |
| Q1 2017 | -3.8% | -2.3% | +2.8% | |
| Q4 2016 | +7.6% | +7.3% | +8.4% | |
| Q3 2016 | -9.0% | -5.1% | -3.0% | |
| Q2 2016 | -0.0% | -3.1% | -3.0% | |
| Q1 2016 | +2.5% | — | — | |
| Q4 2015 | +3.9% | — | — | |
| Q3 2015 | +5.7% | — | — | |
| Q2 2015 | +1.4% | — | — | |
| Q1 2015 | -8.8% | — | — | |
| Q4 2014 | +6.3% | — | — | |
| Q3 2014 | -1.9% | — | — | |
| Q2 2014 | +6.0% | — | — | |
| Q1 2014 | -6.6% | — | — | |
| Q4 2013 | -1.6% | — | — | |
| Q3 2013 | -1.2% | — | — | |
| Q2 2013 | +3.4% | — | — | |
| Q1 2013 | -3.9% | — | — | |
| Q4 2012 | +0.9% | — | — | |
| Q3 2012 | -5.3% | — | — | |
| Q2 2012 | +2.3% | — | — | |
| Q1 2012 | +1.8% | — | — | |
| Q4 2010 | -1.3% | — | — | |
| Q4 2011 | -1.3% | — | — | |
| Q3 2011 | -5.0% | — | — | |
| Q2 2011 | -9.4% | — | — | |
| Q1 2010 | -2.4% | — | — | |
| Q1 2011 | -0.1% | — | — | |
| Q4 2008 | -0.9% | — | — | |
| Q3 2010 | -4.4% | — | — | |
| Q3 2009 | -4.4% | — | — | |
| Q2 2010 | +3.6% | — | — | |
| Q4 2009 | +3.6% | — | — | |
| Q2 2009 | +3.6% | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro